NCT03416751 - Fecal Microbiota Transplantation (FMT) & Liver Fibrosis / Cirrhosis

Study overview:

NCT03416751 - Fecal Microbiota Transplantation (FMT) & Liver Fibrosis / Cirrhosis is a randomized clinical phase I treatment trial studying Fecal Microbiota Transplantation (FMT) in patients with Liver Fibrosis / Cirrhosis

Primary outcome measures:

Safety, proportion of participants with newly acquired transmissible infectious diseases

Results:

No published results were found as of January 2026